Canine Myasthenia Gravis: Managing a Challenging Neuromuscular Disease

Myasthenia gravis in dogs is an autoimmune neuromuscular disease that causes progressive muscle weakness, megaoesophagus, and life-threatening aspiration pneumonia — presenting significant welfare challenges.

Key Facts

Myasthenia gravis (MG) results from autoantibodies attacking acetylcholine receptors at the neuromuscular junction
The most common sign is generalised muscle weakness that worsens with exercise and improves with rest
Megaoesophagus — dilation of the oesophagus causing regurgitation — is present in approximately 90% of dogs with MG
Aspiration pneumonia from regurgitated food entering the airways is the most common cause of death in affected dogs
Breeds predisposed include Labrador Retrievers, Golden Retrievers, German Shepherds, and Newfoundlands
Diagnosis is confirmed by the acetylcholine receptor antibody test, which is highly specific for the acquired form
Immunosuppressive therapy combined with acetylcholinesterase inhibitors (pyridostigmine) is the mainstay of treatment

Welfare Considerations

Myasthenia gravis causes significant and multi-system welfare compromise that demands intensive management. Muscle weakness limits normal activity and enjoyment of exercise; megaoesophagus causes distress from repeated regurgitation and the risk of aspiration; pneumonia causes severe respiratory distress. The management of megaoesophagus — feeding small meals from elevated positions, keeping dogs upright for 20-30 minutes after eating — is time-intensive and requires consistent owner commitment. Dogs that aspirate frequently experience recurrent pneumonia with its associated fever, coughing, and breathing difficulty. Despite the severity of disease, many dogs with MG achieve spontaneous remission within 6-18 months with appropriate treatment, meaning that intensive welfare management during the active disease phase can lead to full recovery. Regular quality-of-life monitoring and open veterinarian-owner communication about prognosis and treatment burden are essential.

What You Can Do

If your dog shows exercise-induced weakness, difficulty swallowing, or regurgitation, seek prompt veterinary assessment
Ask for acetylcholine receptor antibody testing if MG is suspected — it is the definitive diagnostic test
Implement strict feeding management for megaoesophagus — elevated Bailey chair feeding reduces aspiration risk
Monitor for signs of aspiration pneumonia and seek immediate veterinary care if they develop
Work with your veterinarian to assess quality of life honestly and regularly throughout treatment